"Hematoxylin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A dye obtained from the heartwood of logwood (Haematoxylon campechianum Linn., Leguminosae) used as a stain in microscopy and in the manufacture of ink.
| Descriptor ID |
D006416
|
| MeSH Number(s) |
D03.383.663.283.600 D03.633.100.150.600
|
| Concept/Terms |
Hematoxylin- Hematoxylin
- Hemotoxylin
- Hematoxiline
- Hydroxybrasilin
- Hydroxybrazilin
|
Below are MeSH descriptors whose meaning is more general than "Hematoxylin".
Below are MeSH descriptors whose meaning is more specific than "Hematoxylin".
This graph shows the total number of publications written about "Hematoxylin" by people in this website by year, and whether "Hematoxylin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 2 | 2 |
| 2008 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hematoxylin" by people in Profiles.
-
The accuracy of detecting melanoma on frozen section melanoma antigen recognized by T cells 1 (MART-1) stains and on permanent sections of previously frozen tissue: A prospective cohort study. J Am Acad Dermatol. 2021 Jun; 84(6):1764-1766.
-
Deep learning model for the prediction of microsatellite instability in colorectal cancer: a diagnostic study. Lancet Oncol. 2021 01; 22(1):132-141.
-
Pan-cancer image-based detection of clinically actionable genetic alterations. Nat Cancer. 2020 08; 1(8):789-799.
-
Prevalence of bone marrow involvement in systemic anaplastic large cell lymphoma: are immunohistochemical studies necessary? Hum Pathol. 2008 Sep; 39(9):1331-40.
-
Prognostic significance of occult lymph node metastases in node-negative breast cancer. Ann Surg Oncol. 1997 Sep; 4(6):447-51.
-
Prolongation of rat islet allograft survival by the immunosuppressive agent leflunomide. Transplantation. 1997 Mar 15; 63(5):711-6.